Sanjeev Satyal - 30 Sep 2021 Form 3 Insider Report for Monterey Bio Acquisition Corp

Role: Chief Executive Officer
Signature: /s/ Tricia Branker, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 30 Sep 2021
Net transactions value: $0
Form type: 3
Filing time: 30 Sep 2021, 17:49:21 UTC
Next filing: 13 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MTRY	Common Stock						150,000	30 Sep 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares will vest in three equal annual instalments as follows: (i) 50,000 shares on the closing date of a business combination, (ii) 50,000 shares on the first anniversary of the closing date of a business combination and (iii) 50,000 shares on the second anniversary of the closing date of a business combination, subject to the additional terms and conditions of an assignment agreement between NorthStar Bio Ventures, LLC and the Reporting Person.

Content

These shares will vest in three equal annual instalments as follows: (i) 50,000 shares on the closing date of a business combination, (ii) 50,000 shares on the first anniversary of the closing date of a business combination and (iii) 50,000 shares on the second anniversary of the closing date of a business combination, subject to the additional terms and conditions of an assignment agreement between NorthStar Bio Ventures, LLC and the Reporting Person.

Remarks:

See Exhibit 24.1 - Power of Attorney